DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company operates through the following business divisions: Pharmaceuticals manufacturing and distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials manufacturing and distribution. Its products include cough suppressants, expectorants, and mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids, and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections. The company was founded by Kim Ki-Yong on January 19, 1984 and is headquartered in Hoengseong-gun, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company